Results 281 to 290 of about 113,596 (299)

Histone Deacetylase Inhibitors as Anticancer Drugs

International Journal of Molecular Sciences, 2017
Tomáš Eckschlager, Marie Stiborova, Jan Hrabeta   +2 more
exaly  

Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility

American Journal of Obstetrics and Gynecology, 2008
Mark P Hehir, G Nicholas Europe-Finner
exaly  

The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?

EMBO Reports, 2005
Angela Taddei, Daniele Roche, Wendy A Bickmore   +2 more
exaly  

Inhibitors of histone deacetylase as antitumor agents: A critical review

Bioorganic Chemistry, 2016
M J N Chandrasekar
exaly  

Histone deacetylase inhibitors and genomic instability

Cancer Letters, 2009
Christian Jaulin
exaly  

Histone Deacetylase Inhibitors: A Review of Their Clinical Status as Antineoplastic Agents

Cancer Investigation, 2005
Guillermo Garcia-Manero, Jean-Pierre J Issa   +1 more
exaly  

Thioredoxin in cancer—Role of histone deacetylase inhibitors

Seminars in Cancer Biology, 2006
Paul A MarkS
exaly  

The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors

Bioorganic and Medicinal Chemistry Letters, 2014
Vishal Patil, Surendra Jain, Milan Mrksich   +2 more
exaly  

Zinc binding groups for histone deacetylase inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
Qixiao Jiang
exaly  

An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin’s lymphoma

Expert Opinion on Investigational Drugs, 2016
Susmitha Apuri
exaly